Reporting Owner Activity for G. Walmsley Graham

Form 3/4/5 issuer positions and transaction evidence for this reporting owner.

Issuer positions

3

Largest position

Olema Pharmaceuticals, Inc.

Disclosed value

$5.72M

Recent activity

Available

SEC ownership signals 1 fact
Owner positions from Forms 3/4/5

Reported position value

$5,724,000

Estimated from parsed Forms 3/4/5 when the filing discloses holding values.

Reported issuer count

3

Distinct issuers tied to this reporting owner in parsed SEC filings.

Largest reported position

Olema Pharmaceuticals, Inc. (OLMA)

About $5.72M reported in parsed owner filings.

Latest owner filing

09 Dec 2025

Most recent owner-level filing date in the parsed SEC record.

+2 more

Additional issuer positions are listed below.

How to read Forms 3/4/5 positions
  • Reported values are estimates from parsed SEC Forms 3/4/5 when the filing includes enough pricing and share data.
  • Verify the source filing before treating any owner position as current.
Identity 1 fact
Location
San Francisco, CA
SEC filing record 1 fact
SEC signature
/s/ Jonathan Young, Attorney-in-Fact
SEC evidence 1 fact
Source evidence
Open source filing history

Follow Filing Activity

Follow G. Walmsley Graham and return when a new Insider Trading filing changes the record on this page.

This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.

Create free account and return here Already have an account? Sign in and return here

Reported issuer positions for G. Walmsley Graham

Insider Transactions Reported by G. Walmsley Graham:

Sym Company Class Transaction % Reported value Reported price Shares Shares after Date Ownership
* indicates a reported price that failed the local validity check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .